Keywords: pharmion, vidaza, achieves, survival, benefit, mds, usa-based

Pharmion's Vidaza achieves survival benefit in MDS

Article | 17 December 2007

Print This

USA-based drugmaker Pharmion says that Phase III data from a trial of Vidaza (azacitidine for injection) in patients suffering higher-risk ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in